A detailed history of Victory Capital Management Inc transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Victory Capital Management Inc holds 218,531 shares of AMPH stock, worth $8.93 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
218,531
Previous 197,001 10.93%
Holding current value
$8.93 Million
Previous $7.88 Million 34.58%
% of portfolio
0.01%
Previous 0.01%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$36.99 - $50.09 $796,394 - $1.08 Million
21,530 Added 10.93%
218,531 $10.6 Million
Q2 2024

Aug 05, 2024

SELL
$38.65 - $43.48 $606,225 - $681,983
-15,685 Reduced 7.37%
197,001 $7.88 Million
Q1 2024

May 03, 2024

SELL
$42.85 - $63.45 $1.06 Million - $1.57 Million
-24,788 Reduced 10.44%
212,686 $9.34 Million
Q4 2023

Feb 05, 2024

BUY
$44.49 - $62.93 $9.48 Million - $13.4 Million
213,014 Added 870.87%
237,474 $14.7 Million
Q3 2023

Nov 06, 2023

SELL
$45.51 - $65.0 $203,702 - $290,940
-4,476 Reduced 15.47%
24,460 $1.12 Million
Q2 2023

Jul 27, 2023

SELL
$35.77 - $58.38 $529,467 - $864,140
-14,802 Reduced 33.84%
28,936 $1.66 Million
Q1 2023

May 02, 2023

BUY
$27.99 - $37.92 $186,021 - $252,016
6,646 Added 17.92%
43,738 $1.64 Million
Q4 2022

Feb 10, 2023

BUY
$27.93 - $31.27 $90,297 - $101,095
3,233 Added 9.55%
37,092 $1.04 Million
Q4 2022

Feb 09, 2023

SELL
$27.93 - $31.27 $71,724 - $80,301
-2,568 Reduced 7.05%
33,859 $948,000
Q3 2022

Nov 02, 2022

SELL
$27.56 - $37.75 $229,381 - $314,193
-8,323 Reduced 18.6%
36,427 $1.02 Million
Q2 2022

Aug 01, 2022

SELL
$29.79 - $42.29 $534,700 - $759,063
-17,949 Reduced 28.63%
44,750 $1.56 Million
Q1 2022

May 04, 2022

SELL
$22.96 - $36.45 $204,435 - $324,550
-8,904 Reduced 12.44%
62,699 $2.22 Million
Q4 2021

Feb 07, 2022

BUY
$18.14 - $23.29 $454,824 - $583,950
25,073 Added 53.89%
71,603 $1.67 Million
Q3 2021

Nov 02, 2021

BUY
$17.83 - $21.49 $480,643 - $579,305
26,957 Added 137.73%
46,530 $885,000
Q2 2021

Aug 03, 2021

BUY
$17.11 - $20.92 $5,594 - $6,840
327 Added 1.7%
19,573 $395,000
Q1 2021

May 04, 2021

BUY
$17.21 - $20.65 $97,649 - $117,168
5,674 Added 41.81%
19,246 $353,000
Q4 2020

Feb 01, 2021

BUY
$17.76 - $21.24 $18,648 - $22,302
1,050 Added 8.39%
13,572 $273,000
Q3 2020

Nov 09, 2020

SELL
$17.99 - $22.22 $12,377 - $15,287
-688 Reduced 5.21%
12,522 $235,000
Q2 2020

Aug 07, 2020

SELL
$14.25 - $22.46 $194,427 - $306,444
-13,644 Reduced 50.81%
13,210 $297,000
Q1 2020

May 04, 2020

SELL
$12.66 - $20.08 $155,718 - $246,983
-12,300 Reduced 31.41%
26,854 $399,000
Q4 2019

Feb 06, 2020

BUY
$17.07 - $20.64 $33,593 - $40,619
1,968 Added 5.29%
39,154 $755,000
Q4 2019

Feb 04, 2020

BUY
$17.07 - $20.64 $307,806 - $372,180
18,032 Added 94.14%
37,186 $703,000
Q3 2019

Nov 12, 2019

BUY
$19.12 - $22.62 $366,224 - $433,263
19,154 New
19,154 $380,000
Q3 2017

Oct 27, 2017

SELL
$14.73 - $17.99 $82,650 - $100,941
-5,611 Closed
0 $0
Q2 2017

Aug 07, 2017

BUY
N/A
5,611
5,611 $100,000

Others Institutions Holding AMPH

About Amphastar Pharmaceuticals, Inc.


  • Ticker AMPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,015,200
  • Market Cap $2B
  • Description
  • Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...
More about AMPH
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.